- Home
- LPCN vs MYSE Comparison
LPCN vs MYSE Comparison
Compare LPCN & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- MYSE
- Stock Information
- Founded
- LPCN 1997
- MYSE 2014
- Country
- LPCN United States
- MYSE United States
- Employees
- LPCN N/A
- MYSE N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- MYSE Telecommunications Equipment
- Sector
- LPCN Health Care
- MYSE Telecommunications
- Exchange
- LPCN Nasdaq
- MYSE Nasdaq
- Market Cap
- LPCN 13.8M
- MYSE 11.8M
- IPO Year
- LPCN N/A
- MYSE 2021
- Fundamental
- Price
- LPCN $3.18
- MYSE $1.92
- Analyst Decision
- LPCN Strong Buy
- MYSE
- Analyst Count
- LPCN 1
- MYSE 0
- Target Price
- LPCN $7.00
- MYSE N/A
- AVG Volume (30 Days)
- LPCN 54.7K
- MYSE 71.7K
- Earning Date
- LPCN 11-06-2025
- MYSE 11-13-2025
- Dividend Yield
- LPCN N/A
- MYSE N/A
- EPS Growth
- LPCN N/A
- MYSE N/A
- EPS
- LPCN N/A
- MYSE N/A
- Revenue
- LPCN $4,322,693.00
- MYSE $581.00
- Revenue This Year
- LPCN N/A
- MYSE N/A
- Revenue Next Year
- LPCN N/A
- MYSE N/A
- P/E Ratio
- LPCN N/A
- MYSE N/A
- Revenue Growth
- LPCN N/A
- MYSE 12.82
- 52 Week Low
- LPCN $2.52
- MYSE $1.61
- 52 Week High
- LPCN $5.50
- MYSE $9.34
- Technical
- Relative Strength Index (RSI)
- LPCN 61.21
- MYSE 39.13
- Support Level
- LPCN $3.07
- MYSE $1.63
- Resistance Level
- LPCN $3.32
- MYSE $2.16
- Average True Range (ATR)
- LPCN 0.20
- MYSE 0.20
- MACD
- LPCN 0.06
- MYSE -0.04
- Stochastic Oscillator
- LPCN 65.82
- MYSE 40.53
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About MYSE Myseum Inc. Common Stock
Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.